Stefano Di Donato

Leeds, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Longitudinal clinical response to Janus kinase inhibitors in systemic sclerosis: a real-life multicentric study across multiple clinical domains.

Longitudinal clinical response to Janus kinase inhibitors in systemic sclerosis: a real-life multicentric study across multiple clinical domains.

Journal: Clinical rheumatology

Published: January 19, 2026

Defining Enthesitis on Ultrasound in Spondyloarthritis: Lessons From the DEUS Initiative and the Path Forward.

Defining Enthesitis on Ultrasound in Spondyloarthritis: Lessons From the DEUS Initiative and the Path Forward.

Journal: The Journal of rheumatology

Published: January 15, 2026

Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study From the EUSTAR Cohort.

Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study From the EUSTAR Cohort.

Journal: Arthritis care & research

Published: December 01, 2025

Entheseal structural damage according to OMERACT definitions unveils distinct ultrasound phenotypes in SpA: findings from the DEUS multicentre study.

Entheseal structural damage according to OMERACT definitions unveils distinct ultrasound phenotypes in SpA: findings from the DEUS multicentre study.

Journal: Seminars in arthritis and rheumatism

Published: July 19, 2025

Cross-validation and sensitivity to change of EULAR ScleroID as a measure of function and impact of disease in patients with systemic sclerosis.

Cross-validation and sensitivity to change of EULAR ScleroID as a measure of function and impact of disease in patients with systemic sclerosis.

Journal: RMD open

Published: June 16, 2025

Transforming growth factor beta (TGF-β) induces type 1 interferon signalling in systemic sclerosis keratinocytes through the chloride intracellular channel 4 (CLIC4).

Transforming growth factor beta (TGF-β) induces type 1 interferon signalling in systemic sclerosis keratinocytes through the chloride intracellular channel 4 (CLIC4).

Journal: Arthritis research & therapy

Published: April 23, 2025

Reply.

Reply.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: April 16, 2025

Thermographic abnormalities associate with electrocardiogram/echocardiographic changes and mortality in systemic sclerosis: a retrospective cohort study.

Thermographic abnormalities associate with electrocardiogram/echocardiographic changes and mortality in systemic sclerosis: a retrospective cohort study.

Journal: Rheumatology (Oxford, England)

Published: April 12, 2025

Multimodal ultrasound in the assessment of muscle involvement in systemic sclerosis patients: results from a bicentric study.

Multimodal ultrasound in the assessment of muscle involvement in systemic sclerosis patients: results from a bicentric study.

Journal: Rheumatology (Oxford, England)

Published: April 10, 2025

Reply.

Reply.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 21, 2025

Exploiting a unified vascular framework to predict organ-specific complications and accomplish disease modification in systemic sclerosis.

Exploiting a unified vascular framework to predict organ-specific complications and accomplish disease modification in systemic sclerosis.

Journal: The Lancet. Rheumatology

Published: February 26, 2025

Systemic pharmacotherapy approaches for the treatment of systemic sclerosis.

Systemic pharmacotherapy approaches for the treatment of systemic sclerosis.

Journal: Expert opinion on pharmacotherapy

Published: February 21, 2025

Showing 1-12 of 37

Last Updated: 09/26/2026